Karen A. Selz

Karen A. Selz, Ph.D., M.A. is has a diverse background in chemistry and psychology, nonlinear mathematical models of human brain and behavior, applied ergodic theory of dynamical systems to brain physiology (Institute des Hautes Etudes, I.H.E.S., Bures sur Yvette, France, 1993-1994), quantitative characterizations of personality syndromes (Harvard Medical School, McLean Hospital, 1994-1995) and nonlinear dynamics of neurohormonal variables (National Institute of Mental Health, 1995-1996). Dr. Selz has continued her creative productivity in many areas related to quantitative neuroscience and behavior.
Selected examples include:
1. Critical brain stem neuron dynamics: Int. J. Bifurcation and Chaos, 1:717-722, 1991.
2. Influences of intrinsic brain noise on brain stem-neocortical relations: J. Stat. Physics 70:355-373, 1993.
3. Psychopharmacological influences on behavioral scaling exponents: Fractals 3:8 93-904, 1995. Psychoneuroendocrinology 21:173-187, 1995.
4. Entropies as order parameters: Chaos 7:65-82, 1997.
5. Algorithmic sequence analyses and design of functional neuropeptides: Proc. Natl. Acad. Sci. 94:13576-13581, 1997; Physica A244:254-262, 1997; Biopolymers 46:89-101, 1998;Biophys. J. 75:2332-2342, 1998;J. Phys. Chem. 104:3953-3959, 2000; Biophys. J. 86:1308-1331, 2004; Biopolymers 85;38-59, 2007.
6. Multi-ergodic measure characterization of human brain electromagnetic fields: AIP Conference Proc. 1339:7-22, 2011.
7. Autonomous behavioral patterns and shape phase transitions in healthy human white cells: PLoS Computational Biology, 7:1-8, 2011.
Dr. Selz is the founder and current Director of the Cielo Institute, Asheville, NC, where she is also a Senior Scientist. She is also an Associate Research Professor at Emory University School of Medicine, Atlanta, GA; Principle Investigator for nonlinear dynamics of single human and bacterial cell motion for Fetzer-Franklin Trust; and developing a research program relating human behavioral control and brain electromagnetic fields.
She is an inventor on US patents 6,560,542; 6,865,492; and 7,228,238, which comprise ninety-five de novo, brain-targeted peptides and the methods by which such are designed.
Dr. Selz also owns a working horse farm, and is a published writer of numerous short stories and one novel, Key Points (Near Space, 2010).

Main Menu

See Also

Main Menu